This program will provide an overview of BLENREP and the BLENREP Risk Evaluation and Mitigation Strategy (REMS).
The program will last approximately 60 minutes, including a Q&A session.  
Joseph Mikhael, MD
Professor, Applied Cancer Research and Drug Discovery Division, Translational Genomic Research Institute,
Chief Medical Officer, International Myeloma Foundation,
Consultant Hematologist and Director of Myeloma Research, HonorHealth Research Institute,
Phoenix, AZ
Please register for a webinar from the list below:

Please complete the following fields (bold fields are required):


First Name
Last Name
Email Address
Address 1
Address 2
ZIP Code
Phone Number
 Sign up for communications from GSK (optional).
Program Enrollment
GlaxoSmithKline (GSK) believes your privacy is important. By providing your name, address, email address, and other information, you are giving GSK and companies working with GSK permission to market or advertise to you across multiple digital and offline channels, or contact you for market research or other purposes, regarding the medical condition(s) in which you have expressed an interest, as well as other health-related information from GSK. GSK will not sell or transfer your name, address, or email address to any other party for their own marketing use. For additional information regarding how GSK handles your information, please see our privacy statement.
I have read and agree to The Inception Company, LLC
terms and conditions and privacy policy
Notes adds one line break per paragraph after the subform for some reason, so let's start a comment to ignore them all, then finish it in the register form

'Reloading page' image placeholder
Not logged in